113 related articles for article (PubMed ID: 3037773)
1. The genomic RNA of diabetogenic encephalomyocarditis virus: characterization and molecular cloning.
Jordan GW; Cohen SH; Dandekar S; VandenBrink KM
Virology; 1987 Jul; 159(1):120-5. PubMed ID: 3037773
[TBL] [Abstract][Full Text] [Related]
2. Genomic differences between the diabetogenic and nondiabetogenic variants of encephalomyocarditis virus.
Bae YS; Eun HM; Yoon JW
Virology; 1989 May; 170(1):282-7. PubMed ID: 2541543
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the nucleotide sequences of diabetogenic and nondiabetogenic encephalomyocarditis virus.
Cohen SH; Naviaux RK; vanden Brink KM; Jordan GW
Virology; 1988 Oct; 166(2):603-7. PubMed ID: 2845665
[TBL] [Abstract][Full Text] [Related]
4. An apparent deletion of an oligonucleotide detected by RNA fingerprint in the nondiabetogenic B variant of encephalomyocarditis virus is caused by a point mutation.
Yoon JW; Wong AK; Bae YS; Eun HM
J Virol; 1988 Feb; 62(2):637-40. PubMed ID: 2826821
[TBL] [Abstract][Full Text] [Related]
5. Two amino acids, Phe 16 and Ala 776, on the polyprotein are most likely to be responsible for the diabetogenicity of encephalomyocarditis virus.
Bae YS; Eun HM; Pon RT; Giron D; Yoon JW
J Gen Virol; 1990 Mar; 71 ( Pt 3)():639-45. PubMed ID: 1690262
[TBL] [Abstract][Full Text] [Related]
6. Amino acid differences in capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus.
Eun HM; Bae YS; Yoon JW
Virology; 1988 Apr; 163(2):369-73. PubMed ID: 2833013
[TBL] [Abstract][Full Text] [Related]
7. Molecular identification of diabetogenic viral gene.
Bae YS; Eun HM; Yoon JW
Diabetes; 1989 Mar; 38(3):316-20. PubMed ID: 2537245
[TBL] [Abstract][Full Text] [Related]
8. Replication of diabetogenic and nondiabetogenic variants of encephalomyocarditis (EMC) virus in ICR Swiss mice.
Gould CL; Trombley ML; Bigley NJ; McMannama KG; Giron DJ
Proc Soc Exp Biol Med; 1984 Apr; 175(4):449-53. PubMed ID: 6324221
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of two infectious molecular clones of encephalomyocarditis virus.
Naviaux RK; Cohen SH; Vanden Brink KM; Jordan GW
J Virol; 1990 Feb; 64(2):913-7. PubMed ID: 2153252
[TBL] [Abstract][Full Text] [Related]
10. Determination of diabetogenicity attributable to a single amino acid, Ala776, on the polyprotein of encephalomyocarditis virus.
Bae YS; Yoon JW
Diabetes; 1993 Mar; 42(3):435-43. PubMed ID: 8381754
[TBL] [Abstract][Full Text] [Related]
11. Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.
Yoon JW; McClintock PR; Onodera T; Notkins AL
J Exp Med; 1980 Oct; 152(4):878-92. PubMed ID: 6252275
[TBL] [Abstract][Full Text] [Related]
12. Relationship of interferon-inducing particle phenotype to encephalomyocarditis virus-induced diabetes mellitus.
Cohen SH; Bolton V; Jordan GW
Infect Immun; 1983 Nov; 42(2):605-11. PubMed ID: 6315581
[TBL] [Abstract][Full Text] [Related]
13. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells.
Kaptur PE; Thomas DC; Giron DJ
Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein.
Jun HS; Yoon SW; Kang Y; Pak CY; Lee MC; Yoon JW
J Gen Virol; 1995 Oct; 76 ( Pt 10)():2557-66. PubMed ID: 7595359
[TBL] [Abstract][Full Text] [Related]
15. Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies.
Yoon JW; Ko W; Bae YS; Pak CY; Amano K; Eun HM; Kim MK
J Gen Virol; 1988 May; 69 ( Pt 5)():1085-90. PubMed ID: 2836552
[TBL] [Abstract][Full Text] [Related]
16. Virus-induced diabetes mellitus. XXV. Difference in the RNA fingerprints of diabetogenic and non-diabetogenic variants of encephalomyocarditis virus.
Ray UR; Aulakh GS; Schubert M; McClintock PR; Yoon JW; Notkins AL
J Gen Virol; 1983 Apr; 64 (Pt 4)():947-50. PubMed ID: 6300311
[No Abstract] [Full Text] [Related]
17. Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.
Jordan GW; Cohen SH
Rev Infect Dis; 1987; 9(5):917-24. PubMed ID: 2825321
[TBL] [Abstract][Full Text] [Related]
18. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice.
Kang Y; Yoon JW
J Gen Virol; 1993 Jun; 74 ( Pt 6)():1207-13. PubMed ID: 8389806
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice.
Hirasawa K; Ogiso Y; Takeda M; Lee MJ; Itagaki S; Doi K
Lab Anim Sci; 1995 Dec; 45(6):652-6. PubMed ID: 8746525
[TBL] [Abstract][Full Text] [Related]
20. A murine model of insulin-dependent diabetes mellitus resulting from the cumulative effects of the nondiabetogenic strain of encephalomyocarditis virus and a single low dose of streptozocin.
Blay RA; Bigley NJ; Giron DJ
Diabetes; 1985 Dec; 34(12):1288-92. PubMed ID: 2998912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]